FSSAI moves to limit Trans Fats to extend Shelf Life of Heart

New Delhi: Trans fats in food products are wreaking havoc on the health of life. It especially endangers the shelf life of heart. FSSAI has moved to limit Trans fats to minimum to protect hearts’ health in the country. Trans fats are used to extend the shelf life of food products at the cost of human lives. The food regulator has vowed freedom from killer fats by 2022.

With gazette of recent regulation to limit the content of trans fats in all food items, the Food Safety and Standards Authority of India (FSSAI) joins the league of several other nations globally having best practice policies for trans fat elimination.

With enactment of recent regulations on trans fats, India joins the club of around 40 countries globally that have already enacted the best practice policies to eliminate trans fats and would be among the first countries in Asia after Thailand in achieving the best-practice policies in trans fat elimination.

Key pointers under the regulations:

  • Limiting industrial TFA to not more than 3% in all fats and oils by January 2021 and not more than 2% by January, 2022, gazette in December 2020.
  • All food products in which edible oils and fats are used as an ingredient shall not contain industrial trans fatty acids more than 2% by mass of the total oils/fats present in the product, on and from 01st January, 2022 as per the regulation, Food Safety and Standards (Prohibition and Restrictions on Sales) Second Amendment Regulations, 2021gazetted in February 2021
  • Defines “Industrial trans fatty acids (iTFAs) as – all the geometrical isomers of monounsaturated and polyunsaturated fatty acids having non-conjugated, interrupted by at least one methylene group, carbon-carbon double bonds in the trans configuration. It excludes trans-fatty acids from dairy, meat, fish and their products.”

Industrial trans fats are produced by adding hydrogen to liquid vegetable oils to make them solid, which increases their stability at room temperature and extends shelf life. Trans fats are largely present in partially hydrogenated vegetable fats/oils, vanaspati, margarine and bakery shortenings, and can be found in baked and fried foods. Research has shown that higher intakes of industrially produced trans fatty acids (>1% of total energy intake) are associated with increased risk of high cholesterol and heart diseases. According to 2017 estimates, every year more than 1.5 million deaths in India is attributed to coronary heart disease, of which nearly 5% (71,000) are due to trans fats intake

Elimination of iTFA has been recognized as one the modifiable risk factors to prevent heart diseases. This is especially important in the present scenario, when COVID -19 is adding risk to   people suffering from comorbidities like hypertension, heart diseases, diabetes etc. In 2018, WHO called for elimination of industrially-produced trans fat from the food supply by 2023 and released an action package ‘REPLACE’ for the same.

To facilitate the transition towards a Trans Fatty Acids free food supply, FSSAI is also building capacities of the industry and in this regard, recently concluded a series of webinars on trans fats. Each webinar was planned to target specific stakeholders focusing on challenges faced by them towards making a shift to trans fat free products and suggesting practical technological solutions through talks delivered by national and international experts. The webinars were attended by nearly 3,700 participants from the edible oil industry, food businesses, bakers, chefs, restaurateur and hoteliers, sweet and namkeen manufacturers, food analysts from food analytical laboratories and academic institutions.

Related Posts

Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

Domestic Medical Device Leaders cry foul against move to do away with Policy Restrictions New Delhi:  The union government mandarins seem to be at it again, diametrically opposed to Prime…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Healthcare, pharma sector to create 2-2.5 million new jobs by 2030

Healthcare, pharma sector to create 2-2.5 million new jobs by 2030

Over 45% eye infection bacteria drug-resistant, study flags AMR threat

Over 45% eye infection bacteria drug-resistant, study flags AMR threat

Lokayukta Police Launch Multi-City Raids on ADC; Rs 3.37 Crore in Disproportionate Assets Unearthed Across Karnataka

Lokayukta Police Launch Multi-City Raids on ADC; Rs 3.37 Crore in Disproportionate Assets Unearthed Across Karnataka

Alembic Pharma Gets USFDA Nod for Dapagliflozin

Alembic Pharma Gets USFDA Nod for Dapagliflozin

On World Health Day ‘CAHO Na Patient Se Pyaar Hai’

On World Health Day ‘CAHO Na Patient Se Pyaar Hai’